Navigation Links
Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
Date:6/22/2013

ents and 0.0 percent of placebo patients. In addition, investigator-defined hypoglycemia occurred in 0.5 percent of linagliptin patients and 0.0 percent of placebo patients in the monotherapy study, and in 1.0 percent of patients in both groups of the add-on study.3, 4

About the Studies
The first study was a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of linagliptin monotherapy for 24 weeks in Asian patients with inadequately controlled type 2 diabetes mellitus. The study included a total of 300 patients with T2D from China (n=261), Malaysia (n=22) and the Philippines (n=17). Patients who were treatment naïve or who had been treated with one antihyperglycemic drug were randomized to either linagliptin 5 mg daily or placebo following a 4-week washout period of prior drugs. The primary endpoint was change from baseline in mean HbA1c after 24 weeks.3 Mean HbA1c levels at baseline were 7.95 percent for patients in the linagliptin group and 8.09 percent for patients in the placebo group.

The second study, also a randomized, double-blind, placebo-controlled trial, evaluated the efficacy and safety of linagliptin as add-on therapy to metformin in Asian patients with inadequately controlled type 2 diabetes mellitus. The study included a total of 306 patients with T2D from China (n=265), Malaysia (n=17) and the Philippines (n=24). Antihyperglycemic drugs other than metformin were washed out for 4 weeks prior to randomization to either linagliptin 5mg daily or placebo added to metformin. The primary endpoint of the study was change from baseline in mean HbA1c after 24 weeks.4 Mean HbA1c levels at baseline were 7.99 percent for patients in the linagliptin group and 8.00 percent for pa
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... EAST RUTHERFORD, N.J., May 1, 2015 Cambrex Corporation ... ended March 31, 2015. Highlights ... 2014, and increased 27% excluding foreign currency impact, driven by ... $18.0 million from $8.4 million in the first quarter of ... $0.26 versus $0.04 in the first quarter last year and ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
(Date:4/30/2015)... 2015 Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its first quarter ... for the first quarter of 2015 was $116.2 million, ... of 2014, and down $5.3 million or 4.4% from ... 2015 net income as reported in accordance with U.S. ...
Breaking Medicine Technology:Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21
... Managing multiple brands for the same indication is a ... product can translate into expanded market share and improved ... new product gaining market share at the expense of ... of identifying successful strategies and tactics for marketing multiple ...
... Dec. 10, 2010 Tomophase Corporation, developer of ... and other devices, announced today that it has ... Tomophase is a leader in the development ... OCTIS is comprised of a single-use disposable optical ...
Cached Medicine Technology:Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand 2Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 With the success ... company is proud to welcome Neida Miranda and Alex Shields ... Dental Consulting has over 41 years of combined experience working ... been in the dental field for 8 years. She ... in Waco, Texas. Customer service, positive attitude and showing the ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious 2015 ... flagship nutritional supplement, Liquid BioCell™ Life, and the relaunch ... logo, new packaging, new products, and new messaging. ... and promote programs that serve as examples of direct ... International for their outstanding accomplishments and contributions to direct ...
(Date:5/1/2015)... Washington, DC (PRWEB) May 01, 2015 It’s ... Senate and House introducing proposals to expand federal support for ... 22 years that ATA has been working with Congress,” said ... “These actions signify how the nation is poised to embrace ... This is one more step in fulfilling ATA’s mission to ...
(Date:5/1/2015)... Florida (PRWEB) May 01, 2015 The Quail ... the American Cancer Society. Since 2001, the Quail Creek Relay ... Relay team host events throughout the year, including their biggest ... the Golf Ball Drop. , Quail Creek Relay for ... was battling cancer. Kate Kerwin, fitness director, states, “I was ...
(Date:5/1/2015)... The frozen yogurt chain sweetFrog Enterprises is ... and the Myrtle Beach Pellicans (SC). As part of ... offer fans discounts at local sweetFrog locations. , “We ... Luke Shook, co-owner of the Hickory sweetFrog. “Sponsoring ... forward to enjoying the games and the great taste ...
Breaking Medicine News(10 mins):Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... , ST. LOUIS, Nov. 20 ... that it will present at the Bank of America Merrill ... at the Crowne Plaza Hotel Times Square in New York ... a.m. Eastern Time. Investors and other interested parties may access ...
... Journal of the National Cancer Institute discusses the ... of cancer research. The editorial provides guidance for both the ... M. Schwartz, M.D., M.S., and Steven Woloshin, M.D., M.S., of ... for Health Policy and Clinical Practice in New Hampshire, and ...
... short as 34 weeks, potentially adding to preemie delivery rate, experts ... that the rate of preterm deliveries continues to climb in the ... Many women are confused about what constitutes a full-term birth in ... the study considered a baby born at 34 to 36 weeks ...
... , , Project Bread ... , BOSTON, Nov. 20 Project Bread, the state,s ... report on hunger in the Commonwealth. The disquieting trends described ... people in the Commonwealth struggling with hunger. Food insecurity has ...
... Today, iconic denim brand DKNY JEANS and multi-channel ... offered exclusively on HSN and HSN.com for the holiday season. ... Research Hospital,s Thanks and Giving® Program, a holiday fundraising ... healthy kids in your lives and to give to those who ...
... Nov. 20 Fear about the risk of surgery is ... aortic valve replacement surgery, according to a study by physicians ... this year, former First Lady Barbara Bush and comedian Robin ... be missing out on the potentially life-saving surgery. , In ...
Cached Medicine News:Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... was designed for patients with difficult problems ... custom designs to repair difficult anatomic conditions. ... which reduces the chance of dislocation in ... been streamlined and updated so that the ...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
Medicine Products: